Water Island Capital LLC Amarin Corp Plcuk Transaction History

Water Island Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2024	SELL	$0.85 - $1.43 $4,930 - $8,294	-5,800 Reduced 16.57%	29,200 $26,000
Q3 2023 Nov 14, 2023	SELL	$0.85 - $1.43 $4,930 - $8,294	-5,800 Reduced 16.57%	29,200 $27,000
Q2 2023 Nov 14, 2024	BUY	$1.12 - $1.49 $39,200 - $52,150	35,000 New	35,000 $41,000
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.49 $39,200 - $52,150	35,000 New	35,000 $42,000
Q4 2020 Feb 10, 2021	SELL	$4.04 - $5.31 $40,400 - $53,099	-10,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$3.64 - $7.76 $36,400 - $77,600	10,000 New	10,000 $42,000
Q2 2020 Aug 12, 2020	SELL	$4.78 - $8.26 $66,920 - $115,640	-14,000 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$4.0 - $21.53 $56,000 - $301,420	14,000 New	14,000 $56,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Water Island Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Water Island Capital LLC with notifications on news.